AC IMMUNE SA's ticker is ACIU and the CUSIP is H00263105. A total of 61 filers reported holding AC IMMUNE SA in Q2 2021. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $170,293 | -5.5% | 59,752 | -2.0% | 0.00% | – |
| Q2 2023 | $180,113 | +66.4% | 60,952 | +31.8% | 0.00% | – |
| Q1 2023 | $108,218 | +140.5% | 46,247 | +263.9% | 0.00% | – |
| Q2 2022 | $45,000 | -11.8% | 12,707 | 0.0% | 0.00% | – |
| Q1 2022 | $51,000 | -19.0% | 12,707 | 0.0% | 0.00% | – |
| Q4 2021 | $63,000 | -25.9% | 12,707 | 0.0% | 0.00% | – |
| Q3 2021 | $85,000 | -15.8% | 12,707 | 0.0% | 0.00% | – |
| Q2 2021 | $101,000 | +4.1% | 12,707 | 0.0% | 0.00% | – |
| Q1 2021 | $97,000 | +47.0% | 12,707 | 0.0% | 0.00% | – |
| Q4 2020 | $66,000 | +6.5% | 12,707 | 0.0% | 0.00% | – |
| Q3 2020 | $62,000 | -27.9% | 12,707 | 0.0% | 0.00% | – |
| Q2 2020 | $86,000 | +10.3% | 12,707 | +12.5% | 0.00% | – |
| Q1 2020 | $78,000 | – | 11,292 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 7,428,379 | $21,170,880 | 0.57% |
| Avidity Partners Management LP | 2,969,800 | $8,463,930 | 0.34% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,322,462 | $3,769,017 | 0.15% |
| Eversept Partners, LP | 124,589 | $355,079 | 0.03% |
| COHEN LAWRENCE B | 12,850 | $36,623 | 0.02% |
| Banque Cantonale Vaudoise | 80,701 | $231 | 0.01% |
| Renaissance Technologies | 425,179 | $1,212 | 0.00% |
| Handelsbanken Fonder AB | 101,064 | $288 | 0.00% |
| Tower Research Capital LLC (TRC) | 19,638 | $55,968 | 0.00% |
| Compagnie Lombard Odier SCmA | 10,000 | $28,500 | 0.00% |